The company that makes the chips behind the AI boom is buying a piece of the boom itself. TSMC's board approved the two investments at a meeting on Tuesday, November 10, turning the world's largest contract chipmaker into a shareholder in two of its most important customers.

The move is small money for TSMC and a loud signal for the industry. It ties the foundry's fortunes to the labs' equity as well as their orders — and it lands in the same week Anthropic opened its IPO roadshow, with TSMC already named among the buyers of a $26 billion private placement.

The deal in numbers#

The two resolutions are written as ceilings, not completed purchases. Here is what the board actually approved:

InvestmentAmountForm
AnthropicUp to $500 millionCommon shares at the IPO price
OpenAIUp to $500 millionPreferred stock
Combined ceilingUp to $1 billion—

What the resolutions do not say matters as much as what they do. There are no share counts, no ownership percentages, and no closing dates for either investment, and the OpenAI leg carries no price or valuation at all. Approval is permission to spend; whether the full amounts are deployed, and when, is still to be disclosed.

Why the chipmaker is buying in#

TSMC's business is selling advanced manufacturing to the companies racing to build AI. Every frontier model runs on chips it fabricates, and the AI buildout has been the engine of its growth: October revenue rose 60% from a year earlier, the company said the same day, and its shares climbed 4.2% on Wednesday.

Buying stakes in Anthropic and OpenAI extends that exposure from the factory floor to the cap table. The Dow Jones report on the deal described it as TSMC broadening its AI exposure beyond manufacturing the chips that power AI infrastructure. A foundry that owns shares in its customers has a second reason to want them to succeed — and a second way to profit if they do.

The amounts are modest against TSMC's resources. The $1 billion ceiling is about 0.8% of the roughly $126 billion in cash and marketable securities the company held, according to an analysis of its filings. This is a strategic toehold, not a bet-the-company wager.

TSMC Fab 12A in Hsinchu at dusk, with the company's red logo on the building
TSMC Fab 12A in Hsinchu, Taiwan. Photo: 曾 成訓, CC BY 2.0, via Wikimedia Commons

The Anthropic leg rides the IPO#

The Anthropic half of the deal is the straightforward one, because it rides on a transaction already in motion. Anthropic opened its IPO roadshow on November 10, offering shares at $70 to $78, and TSMC Partners Ltd. is listed among the seven buyers of a $26 billion private placement of non-voting shares at the IPO price.

TSMC's $500 million is the smallest commitment in that group — Google and Nvidia are in for $10 billion each, AMD for $2.5 billion, and Microsoft, Broadcom, and Micron for $1 billion each — but it puts the chipmaker on the register before the first public trade. Pricing is expected on November 18, with trading to begin on Nasdaq under the ticker ANT.

The OpenAI leg is a different bet#

OpenAI is a different kind of bet. There is no IPO to price against, and TSMC's resolution says only that it would buy preferred stock — no price, no valuation, no timetable, and no word on which TSMC entity would hold the shares.

Preferred stock typically carries no vote but ranks ahead of common shares if money is ever returned to investors, which makes the OpenAI leg look more like a financial position than a governance play. The contrast with Anthropic is the point: one stake will be priced by a public market within days, while the other is a private negotiation whose terms may never be disclosed.

TSMC Fab 12B at night, windows glowing over a road of light trails
TSMC Fab 12B at night. Photo: 曾 成訓, CC BY 2.0, via Wikimedia Commons

The blurring line analysts are watching#

Analysts quoted in the Dow Jones report were split on what to make of it. The bullish read: the anchor book for Anthropic's IPO now includes the companies that sell it chips, host its models, and distribute its products — a vote of confidence from the supply chain itself.

The cautious read: when a supplier is also an investor and a customer, the lines blur, and it gets harder to tell how much of the demand is real and how much is circular. Pictet Wealth Management made the same point in a report, noting that Anthropic's investors and strategic partners include companies that also provide it with cloud or infrastructure services — deep interdependencies between the lab and the companies that supply it.

What to watch#

Five things to track from here:

  • Whether TSMC deploys the full $500 million in each name — and what ownership that buys, since the resolutions disclose no percentages.
  • Anthropic's pricing on November 18 and its first trade under ANT: the TSMC stake prices off that number.
  • Any terms on the OpenAI preferred stock — price, rights, timing — if TSMC or OpenAI ever discloses them.
  • Whether the rest of the supply chain follows. TSMC's board also approved up to $500 million to set up a semiconductor investment company, suggesting more strategic stakes may be coming.
  • The $40.93 billion in capital spending approved the same day — advanced manufacturing, packaging, plant construction, and 2027 research and development — which dwarfs the $1 billion in lab stakes and is the number that actually builds the chips.